- 020 3313 2115
Mousa Miah, secretary
Dr Neil Ruparelia was awarded his medical degree from University College London in 2004 and also awarded an intercalated degree (BSc) in medical law, receiving numerous prizes and subsequently completed specialist training in general cardiology and specialist coronary and structural through dedicated interventional fellowships in Oxford, London and Milan, Italy.
He was awarded a DPhil (PhD) from Balliol College, University of Oxford funded by a British Heart Foundation Clinical Research Fellowship and an MSc in interventional cardiology from the San Raffaele Scientific Institute in Milan, Italy. He was also the recipient of a British Heart Foundation travel fellowship to the Broad Institute (MIT) and Harvard Medical School (Boston, USA). He is the winner of numerous prizes including the President's Gold Medal in Cardiology from the Royal Society of Medicine and investigator prizes from the European Society of Cardiology (ESC) and American Heart Association (AHA).
Dr Ruparelia is the author of over 150 publications including original papers, editorials, review articles and book chapters and is regularly invited to speak at both national and International conferences and act as a reviewer for a number of international medical journals. In 2017 he was awarded Fellowship of the European Society of Cardiology (FESC) and appointed consultant cardiologist between the Royal Berkshire Hospital, Reading and the Hammersmith Hospital, London. In 2018 he was appointed honorary clinical senior lecturer at Imperial College London.
Research & publications
Dr Ruparelia is actively involved in all aspects of basic science, translational (bench-to-bedside) and clinical research.
In addition to his medical degrees, he was awarded a DPhil (PhD) from Balliol College, University of Oxford in 2013 investigating the monocyte response to acute myocardial infarction and also holds a research MSc in interventional cardiology awarded by the San Raffaele Scientific Institute, Milan, Italy.
Currently, he is actively involved in a number of investigator driven and commercial studies and regularly speaks at national and international meetings, in addition to being a reviewer for a number of high impact factor clinical journals.